IK-930

N/A

Report date: 2024/11/19 20:00:10
NME

Base Information

Drug NameIK-930
Drug Alias NameIK-930
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungHemangioendothelioma, Epithelioid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIkena Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesIkena Oncology Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsSolid tumoursHemangioendothelioma, EpithelioidMesothelioma

Other Information

ATC CodeN/A
Related LinksN/A